Laboratory Tests for Assessing Inflammation in the Body
C-reactive protein (CRP) is the preferred primary inflammatory marker for clinical use due to its superior analytical characteristics, standardization, and established clinical utility. 1
Key Inflammatory Markers
First-Line Inflammatory Markers
C-reactive protein (CRP)
- High-sensitivity CRP (hs-CRP) is the analyte of choice for cardiovascular risk assessment 1
- Produced by liver in response to inflammation
- Risk categories: low risk (<1.0 mg/L), average risk (1.0-3.0 mg/L), high risk (>3.0 mg/L) 1
- Values >10 mg/L suggest acute infection or significant inflammation requiring investigation 1, 2
- More sensitive for acute inflammation; responds quickly to changes 3, 4
Erythrocyte sedimentation rate (ESR)
Second-Line Inflammatory Markers
White blood cell (WBC) count
- Elevated in acute infections and inflammatory conditions 1
- Differential count provides additional information about type of inflammation
Fibrinogen
Serum amyloid A (SAA)
- Acute phase protein that can be elevated in inflammatory conditions 1
Clinical Application of Inflammatory Markers
When to Use CRP vs. ESR
CRP is preferred for:
- Acute inflammatory conditions and infections
- Initial diagnosis of inflammatory conditions
- Monitoring response to therapy
- Cardiovascular risk assessment 1
ESR is preferred for:
Interpretation of Combined CRP and ESR Results
| CRP | ESR | Interpretation |
|---|---|---|
| Elevated | Normal | Acute inflammation (e.g., infections, early inflammation) |
| Normal | Elevated | Chronic inflammation (e.g., autoimmune diseases, stroke) |
| Elevated | Elevated | Active inflammation (both acute and chronic processes) |
| Normal | Normal | Low likelihood of significant inflammation [2] |
CRP/ESR Discordance
Discordance between CRP and ESR occurs in approximately 12% of patients 5:
High CRP/Low ESR pattern is associated with:
- Acute infections (urinary tract, gastrointestinal, pulmonary, bloodstream)
- Myocardial infarction
- Venous thromboembolism 5
High ESR/Low CRP pattern is associated with:
- Connective tissue diseases (e.g., systemic lupus erythematosus)
- Ischemic stroke or transient ischemic attack
- Bone and joint infections 5
Proper Testing Methodology
For optimal CRP assessment:
- Obtain samples when patient is metabolically stable
- Avoid testing during obvious infection or inflammation
- Express results in mg/L only
- Consider two measurements (optimally 2 weeks apart) for stable estimate
- If level is >10 mg/L, search for source of infection/inflammation and repeat test 1
Additional Inflammatory Markers in Specific Contexts
For Rheumatologic Evaluation
- Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) for rheumatoid arthritis 1
- Antinuclear antibodies (ANA) for systemic lupus erythematosus and other autoimmune diseases 2
For Gastrointestinal Inflammation
- Fecal calprotectin for intestinal inflammation 1
For Neurological Inflammation
- Cerebrospinal fluid analysis for central nervous system inflammation 1
Limitations and Pitfalls
- Neither CRP nor ESR is specific for any particular disease
- Both can be elevated in non-inflammatory conditions (obesity can elevate CRP) 2
- Don't treat the marker itself; treat the underlying cause 2
- Always interpret inflammatory markers in clinical context 2
- Don't dismiss elevated ESR when CRP is normal, as this pattern can occur in serious conditions 2
- Avoid assuming low CRP rules out bacterial infection 2
By understanding the characteristics and appropriate use of inflammatory markers, clinicians can more effectively diagnose and monitor inflammatory conditions while avoiding common interpretive errors.